These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11837547)

  • 21. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M; Hsu DI
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
    Vinken A; Li Z; Balan D; Rittenhouse B; Wilike R; Nathwani D
    J Hosp Infect; 2001 Dec; 49 Suppl A():S13-24. PubMed ID: 11926436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN; Shively EH; Polk HC
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
    Kaplan SL; Patterson L; Edwards KM; Azimi PH; Bradley JS; Blumer JL; Tan TQ; Lobeck FG; Anderson DC;
    Pediatr Infect Dis J; 2001 May; 20(5):488-94. PubMed ID: 11368105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.
    Caffrey AR; Quilliam BJ; LaPlante KL
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4394-400. PubMed ID: 20660681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
    Dodds TJ; Hawke CI
    ANZ J Surg; 2009 Sep; 79(9):629-35. PubMed ID: 19895519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid versus vancomycin for skin and soft tissue infections.
    Yue J; Dong BR; Yang M; Chen X; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008056. PubMed ID: 23846850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
    Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
    Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
    Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals.
    Vinken AG; Li JZ; Balan DA; Rittenhouse BE; Willke RJ; Goodman C
    Am J Ther; 2003; 10(4):264-74. PubMed ID: 12845390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
    Shorr AF; Kunkel MJ; Kollef M
    J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.
    Moise PA; Forrest A; Birmingham MC; Schentag JJ
    J Antimicrob Chemother; 2002 Dec; 50(6):1017-26. PubMed ID: 12461026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
    Johnson JR
    Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761
    [No Abstract]   [Full Text] [Related]  

  • 38. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
    Charalampidou S; Connell P; Fennell J; Lynch M; Acheson R
    Br J Ophthalmol; 2007 Dec; 91(12):1723-4. PubMed ID: 18024828
    [No Abstract]   [Full Text] [Related]  

  • 40. Linezolid eradicates MRSA better than vancomycin from surgical-site infections.
    Weigelt J; Kaafarani HM; Itani KM; Swanson RN
    Am J Surg; 2004 Dec; 188(6):760-6. PubMed ID: 15619496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.